Andrew C. Westfall , M.D.

Physician/Surgeon

Biography

Andrew Westfall was born in North Carolina, and raised in Dickinson, North Dakota. He received his B.A. from Drake University and his M.D. from Oregon Health and Sciences University where he was elected to Alpha Omega Alpha a medical honor society. Following medical school, he performed his internship at Providence St. Vincent’s Hospital and then returned to OHSU for his ophthalmology residency at the Casey Eye Institute and received a Distinguished Service Award. His advanced training in vitreoretinal disease was at the Baylor College of Medicine in Houston, Texas. Dr. Westfall has broad experience in all areas of medical and surgical retinal disease and his research has been published in numerous journals and has also authored a chapter on the treatment of vitreoretinal trauma. Dr Westfall joined Dr. Servais and Dr Farmer at Retina Consultants LLC in 2005 and is an associate staff at Casey Eye Institute at OHSU. He is Board Certified and a member of the American Academy of Ophthalmology. He enjoys playing golf and basketball along with spending time with his wife and children.

Curriculum Vitae

Place and Year of Birth:

Boone, North Carolina, 1973

Education:

1995 Bachelor of Arts,
Drake University,
Des Moines, Iowa
1999 Doctor of Medicine,
Oregon Health and Sciences University
Portland, Oregon

Postgraduate Education:

1999-2000 Internship, Preliminary Medicine
Providence St. Vincent’s,
Portland, Oregon
2000-2003 Residency,
Oregon Health and Sciences University,
Department of Ophthalmology,
Casey Eye Institute,
Portland, Oregon
2003-2005 Fellowship,
Baylor College of Medicine,
Department of Ophthalmology,
McPherson Retina Center,
Houston, Texas
2003-Present Clinical Instructor,
Medical and Surgical Disease of Retina and Vitreous,
Baylor College of Medicine,
Houston, Texas

Awards and Honors:

1995-1998 Underrepresented Minority Achievement Scholarship
1996-1997 Hester Scholarship
1998-1999 School of Medicine Scholarship
2002 Distinguished Service Award,
Alpha Omega Alpha
2003 Resident Representative to Faculty Meetings
2004 NEI Travel Grant

Beta Beta Beta, Drake University
Dean’s List, Drake University
Marcus Reidenberg Gateways to Science Program
National Medical Fellowship Award

Licensure:

Texas
Oregon

Medical Specialty:

Vitreoretinal Diseases and Surgery

Professional Affiliations:

American Academy of Ophthalmology
American Medical Association
American Medical Student Association
Association for Research in Vision and Ophthalmology
Houston Ophthalmology Association
Oregon Academy of Ophthalmology

Committee Memberships:

Resident Selection Committee,
Oregon Health and Sciences University
2001-2003 Graduate Education Committee,
Oregon Health and Sciences University

Academic Affiliations:

1986 Clinical Instructor,
Oregon Health Sciences University,
Portland, Oregon
Attending Physician,
U.S. Veterans Administration Hospital,
Portland, Oregon

Clinical Research Experience:

2003-2005 Sub-Investigator,
A Phase II/III Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial in Parallel Groups, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks in Patients with Exudative Age-Related Macular Degeneration. Eyetech Pharmaceuticals, Inc. – EOP 1004, Clinical Study
2003-2005 Sub-Investigator,
A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial in Parallel Groups, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 12 to 30 Weeks to Patients with Clinically Significant Diabetic Macular Edema. Eyetech Pharmaceuticals, Inc. – EOP 1005, Clinical Study
2003-2005 Sub-Investigator,
A Phase III Randomized, Placebo-Controlled, Double-Masked, Multi-Center Trial of the Effect of Visudyne Therapy in Occult with No Classic Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Novartis/QLT - Visudyne in Occult (VIO), Clinical Study
2003-2005 Sub-Investigator,
A Phase III Randomized, Controlled, Double-Masked, Multi-Center Trial, to Compare Oculex Persistent Macular Edema. Oculex, Clinical Study
2003-2005 Principal Investigator,
A Retrospective Review, Incidence of Retinal Tears and Late-stage Breaks in Eyes with Symptomatic Posterior Vitreous Detachments. Baylor University, Clinical Study
2004-2005 Principal Investigator,
A Retrospective Review, Culture-negative and Culture-positive Endophthalmitis Following Intravitreal Steroid Injections. Baylor University, Clinical Study
2003-Present Principal Investigator,
A Retrospective Review, An Investigation into Long-Term Morbidity and Mortality in Optic Nerve Coloboma and Morning Glory Patients. OHSU and Baylor University, Clinical Study

Basic Science Research Experience:

1994 Retina,
Dr. Peter MacLeish's Lab,
Casey Eye Institute
Oregon Health and Sciences University
1998-1999 Glaucoma,
Dr. John Morrison's Lab,
Casey Eye Institute
Oregon Health and Sciences University
1998-2003 Uveitis,
Dr. James Rosenbaum's Lab,
Casey Eye Institute
Oregon Health and Sciences University
2001-2003 Retina/Angiogenesis/Gene Therapy,
Dr. John T Stout’s Lab,
Casey Eye Institute
Oregon Health and Sciences University

Publications:

Westfall A, Suhler E, Lauer A, J Rosenbaum. Toxoplasmosis Retinochoroiditis and Elevated Intraocular Pressure: A Retrospective Study. Journal of Glaucoma; 2005; 14(1): 3-10.
Westfall A, Osborn A, Kuhl D, Benz M, Mieler W, Holz E. Acute Endophthalmitis Incidence: Triamcinolone Acetonide. Archives of Ophthalmology; 2005;123:1075-1077.
Westfall A, Ng J, Weissman J. Radiographic Appearance of Hypotonous Maculopathy (Author Reply). American Journal of Ophthalmology 2004; 138(3): 511-512.
Westfall A, Ng J, Weissman J. Radiographic Appearance of Hypotonous Maculopathy. American Journal of Ophthalmology 2004; 137(3): 563-66.
Westfall A, Mansoor A, Sullivan S, Wilson D, Dailey R. Orbital and Periorbital Myofibromas in childhood: Two Case Reports. Ophthalmology 2003;110(10):2000-5.
Westfall A, Benz M. Controversies in Ocular Trauma. Book Chapter. (In press).
Westfall A, Davis G, Maa A, Mieler W, Holz E. Incidence of Retinal Tears and Late-onset Breaks in Eyes with Symptomatic Posterior Vitreous Detachments. (Submitted to Archives of Ophthalmology)
Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN, Carvounis PE. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology. 2006 Jul;113(7):1174-8. Epub 2006 May 2.
Albini TA, Benz MS, Coffee RE, Westfall AC, Lakhanpal RR, McPherson AR, Holz ER. Optical coherence tomography of idiopathic juxtafoveolar telangiectasia. Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):120-8. [link]

Abstracts:

Westfall A, Osborn A, Kuhl D, Benz M, Mieler, Holz E. Incidence of Acute Endophthalmitis following Intravitreal Triamcinolone Acetonide. [ARVO Abstract, Poster Presentation]. Investigative Ophthalmology and Visual Science, May 2005.
Westfall A, Maa A, Mieler W, Holz E. Incidence of Retinal Tears and Late-onset Breaks in Eyes with Symptomatic Posterior Vitreous Detachments. [ARVO Abstract, Poster Presentation]. Investigative Ophthalmology and Visual Science, April 2004.
Westfall A, McFarland T, Zhang Y, Appukuttan B, Stout JT. Development of a Retina Edema Model Using Intravitreal VEGF and Secondarily Evaluating a Method of Retinal Edema Prevention with Soluble VEGF Receptor 2 (KDR). [ARVO Abstract, Poster Presentation]. Investigative Ophthalmology and Visual Science, May 2003.
Westfall A, Weleber R. Congenital abnormalities of the optic nerve, including coloboma and morning glory disk anomaly (MGDA), are classified based on appearance. [AAPOS Abstract, Poster Presentation], March 2003.
Westfall A, Murthy R, Chen S, McFarland T, Appukuttan B, Stout JT. Production of a Lentiviral Vector containing Tissue Inhibitor of Metalloproteinase 1, an Inhibitor of Angiogenesis. [ARVO Abstract, Poster Presentation], Investigative Ophthalmology and Visual Science, 2002.

Invited Lectures, Presentations and Research Seminars:

Westfall A, “What’s new with Macular Degeneration”, Salem Hospital, April 2006.
Westfall A, “Acute Endophthalmitis Incidence: Triamcinolone Acetonide”, Baylor Alumni Day, June 2004.
Westfall A, “Incidence of Retinal Tears and Late-onset Breaks in Eyes with Symptomatic Posterior Vitreous Detachments”, Baylor Alumni Day, June 2004.
Westfall A, “Large cell Lymphoma”, 15th Annual Midwest Ocular Angiogram Conference, Jasper, Canada, August 2003.
Westfall A, “Retinal Phototoxicity”, 15th Annual Midwest Ocular Angiogram Conference, Jasper, Canada, August 2003.
Westfall A, “Development of a Retina Edema Model Using Intravitreal VEGF and Secondarily Evaluating a Method of Retinal Edema Prevention with Soluble VEGF Receptor 2 (KDR), Casey Eye Institute and Devers Eye Institute Annual Research Day, Portland, Oregon, May 2003.
Westfall A, “Production of a Lentiviral Vector containing Tissue Inhibitor of Metalloproteinase 1, an Inhibitor of Angiogenesis.” Casey Eye Institute and Devers Eye Institute Annual Research Day, Portland, Oregon, May 2002.

Didactic Lectures/Local Presentations:

Westfall A, Flourescein Angiography Conference, Baylor College of Medicine, Houston, Texas, May 2004.
Westfall A, Flourescein Angiography Conference, Baylor College of Medicine, Houston, Texas, December 2003.
Westfall A, “Basics of the Eye Exam”, Casey Eye Institute’s Ophthalmology Course, Portland, Oregon, April 2003.
Westfall A, “Ocular Trauma: Evaluation and Therapy for General Practioners”, Good Samaritan Hospital, Portland, Oregon, December, 2002.
Westfall A, “Basics of the Eye Exam”, Casey Eye Institute’s Ophthalmology Course, Portland, Oregon, April 2002.
Westfall A, “Basics of the Eye Exam”, Casey Eye Institute’s Ophthalmology Course, Portland, Oregon, April 2001.